180 related articles for article (PubMed ID: 35107180)
21. Functional regulation of hypoxia inducible factor-1α by SET9 lysine methyltransferase.
Liu Q; Geng H; Xue C; Beer TM; Qian DZ
Biochim Biophys Acta; 2015 May; 1853(5):881-91. PubMed ID: 25637186
[TBL] [Abstract][Full Text] [Related]
22. Using a yeast two-hybrid system to identify FTCD as a new regulator for HIF-1α in HepG2 cells.
Yu Z; Ge Y; Xie L; Zhang T; Huang L; Zhao X; Liu J; Huang G
Cell Signal; 2014 Jul; 26(7):1560-6. PubMed ID: 24686083
[TBL] [Abstract][Full Text] [Related]
23. Metformin suppresses hypoxia-induced stabilization of HIF-1α through reprogramming of oxygen metabolism in hepatocellular carcinoma.
Zhou X; Chen J; Yi G; Deng M; Liu H; Liang M; Shi B; Fu X; Chen Y; Chen L; He Z; Wang J; Liu J
Oncotarget; 2016 Jan; 7(1):873-84. PubMed ID: 26621849
[TBL] [Abstract][Full Text] [Related]
24. HBx mutants differentially affect the activation of hypoxia-inducible factor-1α in hepatocellular carcinoma.
Liu LP; Hu BG; Ye C; Ho RL; Chen GG; Lai PB
Br J Cancer; 2014 Feb; 110(4):1066-73. PubMed ID: 24346287
[TBL] [Abstract][Full Text] [Related]
25. Urothelial carcinoma associated 1 is a hypoxia-inducible factor-1α-targeted long noncoding RNA that enhances hypoxic bladder cancer cell proliferation, migration, and invasion.
Xue M; Li X; Li Z; Chen W
Tumour Biol; 2014 Jul; 35(7):6901-12. PubMed ID: 24737584
[TBL] [Abstract][Full Text] [Related]
26. Hypoxia-induced overexpression of DEC1 is regulated by HIF-1α in hepatocellular carcinoma.
Ma W; Shi X; Lu S; Wu L; Wang Y
Oncol Rep; 2013 Dec; 30(6):2957-62. PubMed ID: 24100543
[TBL] [Abstract][Full Text] [Related]
27. Inhibition of SIRT1 impairs the accumulation and transcriptional activity of HIF-1α protein under hypoxic conditions.
Laemmle A; Lechleiter A; Roh V; Schwarz C; Portmann S; Furer C; Keogh A; Tschan MP; Candinas D; Vorburger SA; Stroka D
PLoS One; 2012; 7(3):e33433. PubMed ID: 22479397
[TBL] [Abstract][Full Text] [Related]
28. Activation of Hypoxia Inducible Factor-1 Alpha-Mediated DNA Methylation Enzymes (DNMT3a and TET2) Under Hypoxic Conditions Regulates S100A6 Transcription to Promote Lung Cancer Cell Growth and Metastasis.
Wang T; Zhu G; Wang B; Hu M; Gong C; Tan K; Jiang L; Zhu X; Geng Y; Li L
Antioxid Redox Signal; 2024 Mar; ():. PubMed ID: 38299557
[No Abstract] [Full Text] [Related]
29. ENMD-1198, a novel tubulin-binding agent reduces HIF-1alpha and STAT3 activity in human hepatocellular carcinoma(HCC) cells, and inhibits growth and vascularization in vivo.
Moser C; Lang SA; Mori A; Hellerbrand C; Schlitt HJ; Geissler EK; Fogler WE; Stoeltzing O
BMC Cancer; 2008 Jul; 8():206. PubMed ID: 18651980
[TBL] [Abstract][Full Text] [Related]
30. HIF-1α-activated TM4SF1-AS1 promotes the proliferation, migration, and invasion of hepatocellular carcinoma cells by enhancing TM4SF1 expression.
Zeng Z; Shi Z; Liu Y; Zhao J; Lu Q; Guo J; Liu X; Huang D; Xu Q
Biochem Biophys Res Commun; 2021 Aug; 566():80-86. PubMed ID: 34118595
[TBL] [Abstract][Full Text] [Related]
31. Identification of cathepsin B as a novel target of hypoxia-inducible factor-1-alpha in HepG2 cells.
Xiaofei C; Yanqing L; Dongkai Z; Dong C; Feng Z; Weilin W
Biochem Biophys Res Commun; 2018 Sep; 503(2):1057-1062. PubMed ID: 29935187
[TBL] [Abstract][Full Text] [Related]
32. Silencing of hypoxia-inducible factor-1β induces anti-tumor effects in hepatoma cell lines under tumor hypoxia.
Choi SH; Chung AR; Kang W; Park JY; Lee MS; Hwang SW; Kim DY; Kim SU; Ahn SH; Kim S; Han KH
PLoS One; 2014; 9(7):e103304. PubMed ID: 25068796
[TBL] [Abstract][Full Text] [Related]
33. The transcription factor ZFHX3 is crucial for the angiogenic function of hypoxia-inducible factor 1α in liver cancer cells.
Fu C; An N; Liu J; A J; Zhang B; Liu M; Zhang Z; Fu L; Tian X; Wang D; Dong JT
J Biol Chem; 2020 May; 295(20):7060-7074. PubMed ID: 32277050
[TBL] [Abstract][Full Text] [Related]
34. HBXIP drives metabolic reprogramming in hepatocellular carcinoma cells via METTL3-mediated m6A modification of HIF-1α.
Yang N; Wang T; Li Q; Han F; Wang Z; Zhu R; Zhou J
J Cell Physiol; 2021 May; 236(5):3863-3880. PubMed ID: 33305825
[TBL] [Abstract][Full Text] [Related]
35. Plantamajoside inhibits the proliferation and epithelial-to-mesenchymal transition in hepatocellular carcinoma cells via modulating hypoxia-inducible factor-1α-dependent gene expression.
Yin W; Xu J; Li C; Dai X; Wu T; Wen J
Cell Biol Int; 2020 Aug; 44(8):1616-1627. PubMed ID: 32239594
[TBL] [Abstract][Full Text] [Related]
36. HIF-1α promotes the migration and invasion of hepatocellular carcinoma cells via the IL-8-NF-κB axis.
Feng W; Xue T; Huang S; Shi Q; Tang C; Cui G; Yang G; Gong H; Guo H
Cell Mol Biol Lett; 2018; 23():26. PubMed ID: 29881400
[TBL] [Abstract][Full Text] [Related]
37. MiR-338-3p inhibits hepatocarcinoma cells and sensitizes these cells to sorafenib by targeting hypoxia-induced factor 1α.
Xu H; Zhao L; Fang Q; Sun J; Zhang S; Zhan C; Liu S; Zhang Y
PLoS One; 2014; 9(12):e115565. PubMed ID: 25531114
[TBL] [Abstract][Full Text] [Related]
38. [Expressions of hepatitis B virus x protein and hypoxia-inducible factor-1alpha in hepatocellular carcinoma and their possible relationships].
Liu KG; Xie HH; Liu J
Zhonghua Gan Zang Bing Za Zhi; 2007 Feb; 15(2):122-6. PubMed ID: 17362638
[TBL] [Abstract][Full Text] [Related]
39. MiR-29a Curbs Hepatocellular Carcinoma Incidence via Targeting of
Huang YH; Lian WS; Wang FS; Wang PW; Lin HY; Tsai MC; Yang YL
Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163556
[TBL] [Abstract][Full Text] [Related]
40. Comprehensive analysis of the correlations of S100B with hypoxia response and immune infiltration in hepatocellular carcinoma.
Yan J; Huang YJ; Huang QY; Liu PX; Wang CS
PeerJ; 2022; 10():e13201. PubMed ID: 35368338
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]